Tenaya Therapeutics Inc Cash Flow-to-Debt Ratio
Tenaya Therapeutics Inc cash flow-to-debt ratio. Tenaya Therapeutics Inc (TNYA) has a Cash Flow-to-Debt Ratio of -0.71x as of September 2025, meaning its operating cash flow of $-15.60 Million could theoretically repay -1% of its total liabilities ($22.11 Million) in one year. See TNYA free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Tenaya Therapeutics Inc (2019–2024)
Cash flow-to-debt ratio of Tenaya Therapeutics Inc from 2019 to 2024. Historical debt coverage capacity for Tenaya Therapeutics Inc across 6 annual periods. Also explore TNYA net assets growth trend to track the company's year-over-year net asset growth rate.
Tenaya Therapeutics Inc Cash Flow-to-Debt Ratio by Year (2019–2024)
Tenaya Therapeutics Inc cash flow-to-debt ratio by year from 2019 to 2024. Year-by-year debt coverage analysis for Tenaya Therapeutics Inc. For the full cash flow conversion analysis, see cash flow conversion of Tenaya Therapeutics Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -3.34x | $-90.50 Million | $27.09 Million | ▼ -1.8% |
| 2023 | -3.28x | $-102.07 Million | $31.09 Million | ▼ -11.8% |
| 2022 | -2.94x | $-104.42 Million | $35.57 Million | ▼ -84.0% |
| 2021 | -1.60x | $-60.81 Million | $38.12 Million | ▲ +60.7% |
| 2020 | -4.06x | $-35.45 Million | $8.72 Million | ▼ -1278.6% |
| 2019 | -0.29x | $-24.10 Million | $81.74 Million | — |